KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0858 $8.83 Friday, 26th Apr 2024 ATXI stock ended at $6.20. This is 5,199.15% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 52.77% from a day low at $5.78 to a day high of $8.83.
90 days $0.0858 $8.83
52 weeks $0.0858 $8.83

Historical Avenue Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 26, 2024 $7.48 $8.83 $5.78 $6.20 225 631
Apr 25, 2024 $0.0943 $0.120 $0.0858 $0.117 9 700 820
Apr 24, 2024 $0.105 $0.105 $0.0890 $0.0943 12 269 924
Apr 23, 2024 $0.133 $0.135 $0.128 $0.134 281 065
Apr 22, 2024 $0.130 $0.138 $0.114 $0.130 1 602 025
Apr 19, 2024 $0.135 $0.138 $0.125 $0.130 320 569
Apr 18, 2024 $0.135 $0.137 $0.131 $0.135 289 773
Apr 17, 2024 $0.132 $0.139 $0.129 $0.135 804 699
Apr 16, 2024 $0.124 $0.135 $0.122 $0.132 426 444
Apr 15, 2024 $0.139 $0.140 $0.115 $0.125 2 296 297
Apr 12, 2024 $0.144 $0.145 $0.136 $0.136 263 524
Apr 11, 2024 $0.150 $0.155 $0.135 $0.141 1 218 772
Apr 10, 2024 $0.150 $0.151 $0.146 $0.150 301 103
Apr 09, 2024 $0.152 $0.152 $0.146 $0.147 738 858
Apr 08, 2024 $0.150 $0.155 $0.143 $0.154 1 124 213
Apr 05, 2024 $0.143 $0.150 $0.142 $0.149 614 170
Apr 04, 2024 $0.145 $0.153 $0.142 $0.147 313 898
Apr 03, 2024 $0.154 $0.158 $0.144 $0.149 737 353
Apr 02, 2024 $0.150 $0.150 $0.142 $0.150 620 604
Apr 01, 2024 $0.154 $0.156 $0.146 $0.150 570 949
Mar 28, 2024 $0.150 $0.157 $0.147 $0.148 790 979
Mar 27, 2024 $0.155 $0.155 $0.148 $0.153 491 034
Mar 26, 2024 $0.155 $0.156 $0.145 $0.151 1 114 784
Mar 25, 2024 $0.149 $0.160 $0.140 $0.155 2 749 859
Mar 22, 2024 $0.148 $0.158 $0.148 $0.151 1 581 698
Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT